Showing results (1-10 of 3,653) with videos related to
Sort By:
Pageof 366
International Journal of Radiation Oncology, Biology, Physics|August 1, 1982
New agents in ovarian cancerR E SlaytonInvestigational New Drugs|February 1, 1991
A phase II trial of diaziquone (AZQ) in mixed mesodermal sarcomas of the uterus. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, D Clarke-PearsonCancer|September 15, 1988
Primary retroperitoneal pure choriocarcinoma. Two long-term complete responders from a rare fatal diseaseJ F Moss, R E Slayton, S G EconomouInvestigational New Drugs|November 1, 1989
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, M Rettenmaier, et al.Investigational New Drugs|May 1, 1991
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, K Look, et al.American Journal of Clinical Oncology|December 1, 1988
A phase II clinical trial of diaziquone in the treatment of patients with recurrent endometrial carcinoma. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, P J DiSaia, et al.Seminars in Nuclear Medicine|July 1, 1978
Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomasD A Turner, E W Fordham, A Ali, et al.Cancer|March 1, 1985
Retiform differentiation in ovarian Sertoli-Leydig cell tumors. A clinicopathologic study of six cases from a Gynecologic Oncology Group studyL M Roth, R E Slayton, L W Brady, et al.American Journal of Clinical Oncology|October 1, 1983
Phase II study of PALA and AMSA in advanced renal cell carcinomaR H Earhart, P J Elson, S N Rosenthal, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activityR Pazdur, A H Rossof, G Chandra, et al.Pageof 366